text.skipToContent text.skipToNavigation

Maximum quantity allowed is 999

Please select the quantity

CAS RN: 91832-40-5 | Product Number: C3111

Cefdinir


Purity: >97.0%(T)(HPLC)
Synonyms:
Product Documents:
1G
€90.00
Contact Us 18  
5G
€313.00
2   5  

*Stock available in Belgium will be delivered in 1 to 3 days
*Stock available in Japan will be delivered in 1 to 2 weeks (excludes regulated items and dry ice shipments).


Supplemental Product Information:

This product has not been tested for potency and is guaranteed for chemical purity.

Product Number C3111
Purity / Analysis Method >97.0%(T)(HPLC)
Molecular Formula / Molecular Weight C__1__4H__1__3N__5O__5S__2 = 395.41 
Physical State (20 deg.C) Solid
Storage Temperature Room Temperature (Recommended in a cool and dark place, <15°C)
CAS RN 91832-40-5
Reaxys Registry Number 6829362
PubChem Substance ID 253660757
Merck Index (14) 1920
MDL Number

MFCD00865030

Specifications
Appearance White to Light yellow powder to crystal
Purity(HPLC) min. 97.0 area%
Purity(Nonaqueous Titration) min. 97.0 %
Specific rotation [a]20/D -58.0 to -66.0 deg(C=1,0.1mol/L buffer sol. pH7.0 Phosphate)
Properties (reference)
Melting Point 190 °C(dec.)
Specific Rotation -65° (C=1,0.1mol/L pH7.0 phoshate Buffer)
Maximum Absorption Wavelength 295(DMSO) nm
Solubility in water Insoluble
Solubility (insoluble in) Ether, Ethanol
GHS
Pictogram Pictogram
Signal Word Danger
Hazard Statements H317 : May cause an allergic skin reaction.
H334 : May cause allergy or asthma symptoms or breathing difficulties if inhaled.
Precautionary Statements P261 : Avoid breathing dust.
P280 : Wear protective gloves.
P284 : Wear respiratory protection.
P342 + P311 : If experiencing respiratory symptoms: Call a POISON CENTER/doctor.
P304 + P340 : IF INHALED: Remove person to fresh air and keep comfortable for breathing.
P333 + P313 : If skin irritation or rash occurs: Get medical advice/ attention.
Related Laws:
RTECS# XI0367250
Transport Information:
HS Number 2941900000
Application
Cefdinir: A Third-Generation Cephalosporin More Active Against Gram-Positive Organisms

Cefdinir (FK482) is an oral third-generation cephalosporin with vinyl group at the 3-potition and 2-aminothiazolylhydroxyimino group at the 7-potition of 7-ACA [A1266]. Cefdinir has a broad spectrum of activity against many Gram-negative and Gram-positive organisms, but does not have activity against Pseudomonas aeruginosa. Cefdinir is more active than other cephalosporins (e.g. cephalexin [C2248]) against Gram-positive organisms such as Staphylococcus aureus and strains of the Streptococcus group. Cefdinir is stable to hydrolysis by β-lactamases. (The product is for research purpose only.)

References


PubMed Literature


TCIMAIL
Product Documents (Note: Some products will not have analytical charts available.)
Safety Data Sheet (SDS)
Please select Language.

The requested SDS is not available.

Please Contact Us for more information.

Specifications
C of A & Other Certificates
Please enter Lot Number Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.

The product with the lot number searched for has been discontinued and no related documentation is available.

Sample C of A
This is a sample C of A and may not represent a recently manufactured lot of the product.

A sample C of A for this product is not available at this time.

Analytical Charts
Please enter Lot Number Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.

The requested analytical chart is not available. Sorry for the inconvenience.

The product with the lot number searched for has been discontinued and no related documentation is available.

Other Documents

Session Status
Your session will timeout in 10 minutes. You will be redirected to the HOME page after session timeout. Please click the button to continue session from the same page. minute. You will be redirected to the HOME page after session timeout. Please click the button to continue session from the same page.

Your session has timed out. You will be redirected to the HOME page.